NEW YORK, Nov. 13, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Leucadia National Corporation (NYSE:LUK), Matador Resources Company (NYSE:MTDR), Bemis Company, Inc. (NYSE:BMS), Capricor Therapeutics, Inc. (NASDAQ:CAPR), IZEA, Inc. (NASDAQ:IZEA), and Comcast Corporation (NASDAQ:CMCSA) including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
LUK DOWNLOAD: http://Fundamental-Markets.com/register/?so=LUK
MTDR DOWNLOAD: http://Fundamental-Markets.com/register/?so=MTDR
BMS DOWNLOAD: http://Fundamental-Markets.com/register/?so=BMS
CAPR DOWNLOAD: http://Fundamental-Markets.com/register/?so=CAPR
IZEA DOWNLOAD: http://Fundamental-Markets.com/register/?so=IZEA
CMCSA DOWNLOAD: http://Fundamental-Markets.com/register/?so=CMCSA
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Leucadia National Corporation (NYSE:LUK), Matador Resources Company (NYSE:MTDR), Bemis Company, Inc. (NYSE:BMS), Capricor Therapeutics, Inc. (NASDAQ:CAPR), IZEA, Inc. (NASDAQ:IZEA), and Comcast Corporation (NASDAQ:CMCSA) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today’s readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. All information in this release was accessed November 12, 2017. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All amounts in millions (except per share amounts).
-----------------------------------------
LEUCADIA NATIONAL CORPORATION (LUK) REPORT OVERVIEW
Leucadia National's Recent Financial Performance
For the three months ended September 30, 2017 vs September 30, 2016, Leucadia National reported revenue of $3,141.9 vs $2,883.7 (up 9.0%), diluted earnings per share $0.27 vs $0.41 (down 34.2%), and dividends per share $0.1000 vs $0.0625 (up 60.0%). For the twelve months ended December 31, 2016 vs December 31, 2015, Leucadia National reported net revenue of $10,062.6 vs $10,886.5 (down 7.6%), diluted earnings per share $0.34 vs $0.74 (down 54.1%), and dividends per share $0.25 vs $0.25 (unchanged).
To read the full Leucadia National Corporation (LUK) report, download it here: http://Fundamental-Markets.com/register/?so=LUK
-----------------------------------------
MATADOR RESOURCES COMPANY (MTDR) REPORT OVERVIEW
Matador Resources' Recent Financial Performance
For the three months ended September 30, 2017 vs September 30, 2016, Matador Resources reported revenue of $126.3 vs $88.7 (up 42.4%) and diluted earnings per share $0.15 vs $0.13 (up 15.4%). For the twelve months ended December 31, 2016 vs December 31, 2015, Matador Resources reported revenue of $264.4 vs $318.0 (down 16.9%) and diluted earnings per share -$1.07 vs -$8.34.
To read the full Matador Resources Company (MTDR) report, download it here: http://Fundamental-Markets.com/register/?so=MTDR
-----------------------------------------
BEMIS COMPANY, INC. (BMS) REPORT OVERVIEW
Bemis Company's Recent Financial Performance
For the three months ended September 30, 2017 vs September 30, 2016, Bemis Company reported revenue of $1,035.1 vs $1,027.2 (up 0.8%), diluted earnings per share $0.61 vs $0.72 (down 15.3%), and dividends per share $0.30 vs $0.29 (up 3.5%). For the twelve months ended December 31, 2016 vs December 31, 2015, Bemis Company reported revenue of $4,004.4 vs $4,071.4 (down 1.7%), diluted earnings per share $2.48 vs $2.47 (up 0.4%), and dividends per share $1.16 vs $1.12 (up 3.6%).
To read the full Bemis Company, Inc. (BMS) report, download it here: http://Fundamental-Markets.com/register/?so=BMS
-----------------------------------------
CAPRICOR THERAPEUTICS, INC. (CAPR) REPORT OVERVIEW
Capricor Therapeutics' Recent Financial Performance
For the three months ended June 30, 2017 vs June 30, 2016, Capricor Therapeutics reported revenue of $1.0 vs $1.1 (down 9.1%) and diluted earnings per share -$0.16 vs -$0.26. For the twelve months ended December 31, 2016 vs December 31, 2015, Capricor Therapeutics reported revenue of $4.0 vs $5.5 (down 27.3%) and diluted earnings per share -$1.01 vs -$0.81.
To read the full Capricor Therapeutics, Inc. (CAPR) report, download it here: http://Fundamental-Markets.com/register/?so=CAPR
-----------------------------------------
IZEA, INC. (IZEA) REPORT OVERVIEW
IZEA's Recent Financial Performance
For the three months ended September 30, 2017 vs September 30, 2016, IZEA reported revenue of $8.15 vs $7.50 (up 8.7%) and diluted earnings per share -$0.10 vs -$0.28. For the twelve months ended December 31, 2016 vs December 31, 2015, IZEA reported revenue of $27.3 vs $20.5 (up 33.2%) and diluted earnings per share -$1.41 vs -$3.03.
To read the full IZEA, Inc. (IZEA) report, download it here: http://Fundamental-Markets.com/register/?so=IZEA
-----------------------------------------
COMCAST CORPORATION (CMCSA) REPORT OVERVIEW
Comcast's Recent Financial Performance
For the three months ended September 30, 2017 vs September 30, 2016, Comcast reported revenue of $20,983 vs $21,319 (down 1.6%), diluted earnings per share $0.55 vs $0.46 (up 19.6%), and dividends per share $0.1575 vs $0.1375 (up 14.6%). For the twelve months ended December 31, 2016 vs December 31, 2015, Comcast reported revenue of $80,403 vs $74,510 (up 7.9%), diluted earnings per share $3.57 vs $3.24 (up 10.2%), and dividends per share $1.10 vs $1.00 (up 10.0%).
To read the full Comcast Corporation (CMCSA) report, download it here: http://Fundamental-Markets.com/register/?so=CMCSA
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world’s leading brokerages for over a decade—and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets’ roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets’ oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets’ roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets’ Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]
© 2017 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.


xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 



